Innovation Pharmaceuticals Inc (IPIX)

[DaubersUP]

Yes, it was a 2 cohort dose escalation. The trial was extremely difficult to recruit and I recall a phenomenal post by an intelligent investor here that explained why and I’ll have to go back and look for that unless someone has it on hand! Thx.

The trial was moving slow and the primary was to validate p53 modulation within the tumor via biopsy etc... well they saw it and that was it. Our explanation from mgmt: we saw we conquered and need to focus on Oral and asap! No more money to waste on that trial is what I came away with.

I sent an email to IPIX about a better explanation. I think we will understand shortly in more detail.